Karyopharm Therapeutics reported $3.9M in Stock for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Stock Change
Amgen AMGN:US $ 4115M 98M
Bristol Myers Squibb BMY:US $ 2137M 184M
Eli Lilly And LLY:US $ 3824.9M 164.1M
Epizyme EPZM:US 1.07M 13.74M
GlaxoSmithKline GSK:LN 6330M 114M
Karyopharm Therapeutics KPTI:US $ 3.9M 791K
Nektar Therapeutics NKTR:US $ 14.62M 2.19M
Novartis NOVN:VX SF 7111M 114M
Regeneron Pharmaceuticals REGN:US $ 1983.9M 318.6M
Ultragenyx Pharmaceutical RARE:US $ 15.08M 2.62M
YTE INCY:US $ 16.68M 0.02M